| 1 |
30936876 | Prostaglanin-E2 Potentiates the Suppressive Functions of Human Mononuclear Myeloid-Derived Suppressor Cells and Increases Their Capacity to Expand IL-10-Producing Regulatory T Cell Subsets. | 2019 |
1 |
| 2 |
31122145 | Differential Immunomodulatory Effects of Human Bone Marrow-Derived Mesenchymal Stromal Cells on Natural Killer Cells. | 2019 Jul 15 |
1 |
| 3 |
28765120 | Constitutive IDO1 Expression in Human Tumors Is Driven by Cyclooxygenase-2 and Mediates Intrinsic Immune Resistance. | 2017 Aug |
4 |
| 4 |
25815345 | PGE2-induced IDO1 inhibits the capacity of fully mature DCs to elicit an in vitro antileukemic immune response. | 2015 |
6 |
| 5 |
24391212 | The SOCS3-independent expression of IDO2 supports the homeostatic generation of T regulatory cells by human dendritic cells. | 2014 Feb 1 |
2 |
| 6 |
25060643 | Cancer/stroma interplay via cyclooxygenase-2 and indoleamine 2,3-dioxygenase promotes breast cancer progression. | 2014 Jul 25 |
3 |
| 7 |
23973990 | Cyclooxygenase-2 (COX-2) inhibition constrains indoleamine 2,3-dioxygenase 1 (IDO1) activity in acute myeloid leukaemia cells. | 2013 Aug 22 |
1 |
| 8 |
22539287 | Ambivalent effects of dendritic cells displaying prostaglandin E2-induced indoleamine 2,3-dioxygenase. | 2012 May |
3 |
| 9 |
23369567 | Generation of myeloid-derived suppressor cells using prostaglandin E2. | 2012 Sep 28 |
1 |
| 10 |
17195079 | Dendritic cell based antitumor vaccination: impact of functional indoleamine 2,3-dioxygenase expression. | 2007 Jul |
2 |
| 11 |
17698915 | Prostaglandin E2 is a key factor for monocyte-derived dendritic cell maturation: enhanced T cell stimulatory capacity despite IDO. | 2007 Nov |
4 |
| 12 |
16522817 | CD25 and indoleamine 2,3-dioxygenase are up-regulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in vivo: additional mechanisms of T-cell inhibition. | 2006 Jul 1 |
9 |